192 related articles for article (PubMed ID: 15645064)
1. [Neuropatological and neurochemical abnormalities in bipolar disorder].
Frey BN; Fonseca MM; Machado-Vieira R; Soares JC; Kapczinski F
Braz J Psychiatry; 2004 Sep; 26(3):180-8. PubMed ID: 15645064
[TBL] [Abstract][Full Text] [Related]
2. Neuropathology of bipolar disorder.
Vawter MP; Freed WJ; Kleinman JE
Biol Psychiatry; 2000 Sep; 48(6):486-504. PubMed ID: 11018222
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical underpinnings in bipolar disorder and epilepsy.
Amann B; Grunze H
Epilepsia; 2005; 46 Suppl 4():26-30. PubMed ID: 15938708
[TBL] [Abstract][Full Text] [Related]
4. Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder.
Niciu MJ; Ionescu DF; Mathews DC; Richards EM; Zarate CA
CNS Spectr; 2013 Oct; 18(5):242-51. PubMed ID: 23472710
[TBL] [Abstract][Full Text] [Related]
5. The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder.
Hu LW; Kawamoto EM; Brietzke E; Scavone C; Lafer B
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):11-7. PubMed ID: 20828594
[TBL] [Abstract][Full Text] [Related]
6. [Physiopathology of bipolar disorders: what have changed in the last 10 years?].
Kapczinski F; Frey BN; Zannatto V
Braz J Psychiatry; 2004 Oct; 26 Suppl 3():17-21. PubMed ID: 15597134
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction pathways in the pathophysiology of bipolar disorder.
Gawryluk JW; Young LT
Curr Top Behav Neurosci; 2011; 5():139-65. PubMed ID: 25236554
[TBL] [Abstract][Full Text] [Related]
8. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium.
Stewart RJ; Chen B; Dowlatshahi D; MacQueen GM; Young LT
Brain Res Bull; 2001 Jul; 55(5):625-9. PubMed ID: 11576759
[TBL] [Abstract][Full Text] [Related]
10. The neurobiology of bipolar disorder: findings using human postmortem central nervous system tissue.
Dean B
Aust N Z J Psychiatry; 2004 Mar; 38(3):135-40. PubMed ID: 14961931
[TBL] [Abstract][Full Text] [Related]
11. The calcium second messenger system in bipolar disorders: data supporting new research directions.
Dubovsky SL; Murphy J; Christiano J; Lee C
J Neuropsychiatry Clin Neurosci; 1992; 4(1):3-14. PubMed ID: 1320969
[TBL] [Abstract][Full Text] [Related]
12. Neurobiology of bipolar illness: implications for future study and therapeutics.
Post RM; Speer AM; Hough CJ; Xing G
Ann Clin Psychiatry; 2003 Jun; 15(2):85-94. PubMed ID: 12938866
[TBL] [Abstract][Full Text] [Related]
13. Toward a biaxial model of "bipolar" affective disorders: spectrum phenotypes as the products of neuroelectrical and neurochemical alterations.
Askland K; Parsons M
J Affect Disord; 2006 Aug; 94(1-3):15-33. PubMed ID: 16725206
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.
Cecil KM; DelBello MP; Sellars MC; Strakowski SM
J Child Adolesc Psychopharmacol; 2003; 13(4):545-55. PubMed ID: 14977467
[TBL] [Abstract][Full Text] [Related]
15. New insights help define the pathophysiology of bipolar affective disorder: neuroimaging and neuropathology findings.
Haldane M; Frangou S
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):943-60. PubMed ID: 15380855
[TBL] [Abstract][Full Text] [Related]
16. Changes in the molecular structure of the brain in bipolar disorder: findings using human postmortem brain tissue.
Dean B
World J Biol Psychiatry; 2002 Jul; 3(3):125-32. PubMed ID: 12478877
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment.
de Bartolomeis A; Buonaguro EF; Iasevoli F; Tomasetti C
J Psychopharmacol; 2014 Jun; 28(6):505-26. PubMed ID: 24554693
[TBL] [Abstract][Full Text] [Related]
18. The neuropathology of bipolar disorder: systematic review and meta-analysis.
Harrison PJ; Colbourne L; Harrison CH
Mol Psychiatry; 2020 Aug; 25(8):1787-1808. PubMed ID: 30127470
[TBL] [Abstract][Full Text] [Related]
19. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
[TBL] [Abstract][Full Text] [Related]
20. Neuropathological and neuromorphometric abnormalities in bipolar disorder: view from the medial prefrontal cortical network.
Savitz JB; Price JL; Drevets WC
Neurosci Biobehav Rev; 2014 May; 42():132-47. PubMed ID: 24603026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
